Biotech

Feinstein stimulates talk of an arthritis breakthrough

By GREGORY ZELLER // An encouraging new study out of the Feinstein Institute for Medical Research says noninvasive bioelectronic stimulation – administered through the outer ear – can effectively reduce symptoms of rheumatoid arthritis. The potentially quantum leap for the treatment of RA and other inflammatory diseases was reported Tuesday in Bioelectronic Medicine, an open-access journal aggregating articles and data from across a dozen-plus basic and clinical disciplines, including biochemistry, neuroscience, bioengineering, artificial intelligence and…

Read More

For Applied DNA, ETCH Biotrace may be a pot of gold

By GREGORY ZELLER // Just six months after announcing a partnership to develop a new molecular-tracking system, a Long Island biotech and a Canadian medical-marijuana supplier are launching the world’s first cannabis tagging system. Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist Applied DNA Sciences and Calgary-based pharmaceutical-solutions provider TheraCann International Benchmark Corp. on Tuesday announced the launch of ETCH Biotrace, which leverages Applied DNA’s CertainT platform to tag, test and track cannabis plants “in…


Nerve-stim startup Sanguistat shuffles its deck

By GREGORY ZELLER // A Connecticut-based biotech spun out of the Feinstein Institute for Medical Research has assembled a powerful collection of advisors and directors, including corporate heavyweights and recognized global leaders in the burgeoning field of biolelectronic medicine. Sanguistat Inc., a 2016 clinical-stage medical-device startup, has named Feinstein Institute President and CEO Kevin Tracey as chairman of its Scientific Advisory Board, a role that will leverage the pioneer’s decades of groundbreaking bioelectronics research. The…


In Applied DNA’s new UL partnership, it’s safety first

By GREGORY ZELLER // A new deal with a worldwide safe-sciences leader will expand a Long Island innovator’s already-impressive global reach. Illinois-based UL, known primarily as Underwriters Laboratories for most of its 124-year history, has reached a “commercial agreement” with Applied DNA Sciences that will “lay the foundation for a significant new development in product authentication and supply-chain traceability,” according to a statement from Applied DNA. Financial terms were not disclosed, but the partnership will…


At FSC, skin-deep startup joins Start-Up NY’s ranks

By GREGORY ZELLER // The Empire State Development Corp. has opened its books and welcomed another Long Island company into the Start-Up NY family. Farmingdale State College announced this week that startup biotech BF Innovation, which moved into FSC’s Broad Hollow Bioscience Park earlier this year, has been accepted into the Start-Up NY program, which boosts new and expanding businesses with tax breaks and innovative academic partnerships. BF Innovation plans to invest $1 million and…


Albany backs NYIT’s next-gen bioengineering lab

By GREGORY ZELLER // A new bioengineering laboratory is coming to the New York Institute of Technology’s Old Westbury campus, thanks to a hefty state award. The Empire State Development Corp. on Wednesday announced a $150,000 grant that will help NYIT establish the Bio-Nanotechnology and Biomaterials Laboratory, a research- and innovation-focused bioengineering lab packed with next-level tech facilitating specialized research into complex bioengineering, artificial-intelligence and life-sciences issues. The grant was awarded through Round 7 of…


SBU joins elite HHS business-development task force

By GREGORY ZELLER // Stony Brook University will join an elite roster of national institutions in a new business-development feeder system devised by the U.S. Department of Health & Human Services. Introduced Tuesday as a business-accelerator program under the auspices of BARDA, HHS’s Biomedical Advanced Research and Development Authority, the nationwide network will foster development of new “health security” protocols – that is, preparedness to respond to threats ranging from chemical attacks and radiological terrorism…